Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-058820

Chief Executive Officer sold 7,800 shares at an average $34.62 ($270,052)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-11-14 Sale : show line 1 in the form −3,300 $33.89 $111,837 39,778 I
2018-11-14 Sale : show line 2 in the form −600 $34.51 $20,706 39,178 I
2018-11-15 Sale : show line 3 in the form −1,100 $34.67 $38,137 38,078 I
2018-11-15 Sale : show line 4 in the form −2,800 $35.49 $99,372 35,278 I
Open-market sales · 7,800 sh · avg $34.62 · $270,052
Loading xslF345X03/doc4.xml…